Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SOMATROPIN Cause Drug ineffective? 1,100 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,100 reports of Drug ineffective have been filed in association with SOMATROPIN (Nutropin AQ NuSpin 10). This represents 1.6% of all adverse event reports for SOMATROPIN.

1,100
Reports of Drug ineffective with SOMATROPIN
1.6%
of all SOMATROPIN reports
3
Deaths
61
Hospitalizations

How Dangerous Is Drug ineffective From SOMATROPIN?

Of the 1,100 reports, 3 (0.3%) resulted in death, 61 (5.5%) required hospitalization, and 2 (0.2%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SOMATROPIN. However, 1,100 reports have been filed with the FAERS database.

What Other Side Effects Does SOMATROPIN Cause?

Drug dose omission by device (15,921) Device leakage (9,113) Device breakage (7,761) Device mechanical issue (6,411) Device information output issue (5,220) Device issue (5,131) Wrong technique in device usage process (4,746) Injection site pain (4,009) Poor quality device used (3,162) Device use error (2,801)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which SOMATROPIN Alternatives Have Lower Drug ineffective Risk?

SOMATROPIN vs SONIDEGIB SOMATROPIN vs SORAFENIB SOMATROPIN vs SORGHUM HALEPENSE POLLEN SOMATROPIN vs SOTAGLIFLOZIN SOMATROPIN vs SOTALOL

Related Pages

SOMATROPIN Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective SOMATROPIN Demographics